Nervous system disorder (paresthesia, peripheral motor neuropathy, or peripheral sensory neuropathy) >= grade , per the Common Terminology Criteria for Adverse Events (CTCAE) version (v).
STEP I: Patients must not have grade  or higher peripheral neuropathy by Common Terminology Criteria for Adverse Events (CTCAE) .
Symptomatic peripheral sensory neuropathy >= grade  (Common Terminology Criteria for Adverse Events [CTCAE] version [v] .) in patients with no prior oxaliplatin therapy
Symptomatic peripheral neuropathy >= grade  Common Terminology Criteria for Adverse Events (CTCAE) version (v) . (for participants receiving docetaxel only)
Peripheral sensory neuropathy >/= Common Terminology Criteria for Adverse Events (CTCAE) Grade 
Pre-existing, clinically significant peripheral neuropathy, defined as Common Terminology Criteria for Adverse Events (CTCAE) grade  or higher neurosensory or neuromotor toxicity, regardless of etiology
Presence of grade >=  Common Terminology Criteria for Adverse Events (CTCAE) toxicity (CTCAE grade  peripheral neuropathy and ototoxicity and any grade alopecia are allowed)
Patients must have < grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE])
Has pre-existing peripheral neuropathy that is ? Grade  by Common Terminology Criteria for Adverse Events (CTCAE) version  criteria.
Subjects must have < grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE])
STUDY TREATMENT: Peripheral neuropathy less than or equal to Common Terminology Criteria for Adverse Events (CTCAE) grade .
Presence of ? Common Terminology Criteria for Adverse Events (CTCAE) grade  toxicity due to prior cancer therapy (except alopecia, peripheral neuropathy which are excluded if ? CTCAE grade )
Patients with peripheral neuropathy > Common Terminology Criteria for Adverse Events (CTCAE) grade 
No Common Terminology Criteria for Adverse Events (CTCAE) v grade >  neuropathy
Nervous system disorder (i.e., paresthesia, peripheral motor neuropathy, or peripheral sensory neuropathy) >= grade , per Common Terminology Criteria for Adverse Events (CTCAE) version (v).
Presence of >= Common Terminology Criteria for Adverse Events (CTCAE) grade  toxicity (except alopecia or peripheral neuropathy) due to prior cancer therapy
Peripheral neuropathy ? grade  (Common Terminology Criteria for Adverse Events CTCAE)
Pre-existing peripheral neuropathy > grade  (using Common Terminology Criteria for Adverse Events [CTCAE] version [v] . criteria)
Must have =< grade  pre-existing peripheral neuropathy (as per Common Terminology Criteria for Adverse Events [CTCAE])
Patients must have < grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE])
Grade  or worse peripheral neuropathy as defined by Common Terminology Criteria for Adverse Events (CTCAE) v.
Peripheral neuropathy =< Common Terminology Criteria for Adverse Events (CTCAE) grade 
Patients must have < grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE])
Pre-existing peripheral neuropathy that is >= grade  by Common Terminology Criteria for Adverse Events (CTCAE) v . criteria
Nervous system disorder (paresthesias, peripheral motor neuropathy, or peripheral sensory neuropathy) >= grade , per the Common Terminology Criteria for Adverse Events version . (CTCAE v.)
Patients must have < grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE])
Patients must have < grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE])
Patients with =< grade  peripheral neuropathy are eligible for this trial using the Common Terminology Criteria for Adverse Events (CTCAE) version (v)., regardless of use of therapy for neuropathy including gabapentin
Presence of CTCAE (Common Terminology Criteria for Adverse Events) grade ?  peripheral neuropathy.
Peripheral neuropathy of Common Terminology Criteria for Adverse Events (CTCAE) v. grade >= 
Nervous system disorder (paresthesia, peripheral motor neuropathy, or peripheral sensory neuropathy) >= grade , per the Common Terminology Criteria for Adverse Events (CTCAE) version (v) .
Peripheral neuropathy of grade  or greater by Common Terminology Criteria for Adverse Events (CTCAE) .. In CTCAE version . grade  sensory neuropathy is defined as moderate symptoms; limiting instrumental activities of daily living (ADLs).
Pre-existing peripheral neuropathy that is >= grade  by Common Terminology Criteria for Adverse Events (CTCAE) v criteria
Sensory peripheral neuropathy > Common Terminology Criteria for Adverse Events (CTCAE) grade 
Patients with peripheral neuropathy >= Common Terminology Criteria for Adverse Events (CTCAE) grade  are ineligible
Sensory peripheral neuropathy =< grade  (per Common Terminology Criteria for Adverse Events [CTCAE] version [v.] .)
Patients with pre-treatment peripheral neuropathy greater than grade  per the Common Terminology Criteria for Adverse Events (CTCAE), version . will be excluded
Symptomatic peripheral neuropathy > grade  by Common Terminology Criteria for Adverse Events (CTCAE) criteria
Nervous system disorder (paresthesia, peripheral motor neuropathy, or peripheral sensory neuropathy) >= grade , per the Common Terminology Criteria for Adverse Events version . (CTCAE v.)
Pre-existing peripheral neuropathy, if present, must be < grade  (per Common Terminology Criteria for Adverse Events [CTCAE] version .)
Preexisting peripheral neuropathy of Grade , , or  (per Common Terminology Criteria for Adverse Events v.).
For Cohort B: Has peripheral neuropathy Common Terminology Criteria for Adverse Events ? except due to trauma
Peripheral neuropathy >= grade  (per Common Terminology Criteria for Adverse Events [CTCAE] version [v])
Presence of peripheral neuropathy ? Common Terminology Criteria for Adverse Events (CTCAE) Grade 
Patients must have < grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE])
Peripheral neuropathy Common Terminology Criteria for Adverse Events (CTCAE) grade  or higher
Peripheral neuropathy of grade  or greater by Common Terminology Criteria for Adverse Events (CTCAE) .; in CTCAE version . grade  sensory neuropathy is defined as \moderate symptoms; limiting instrumental activities of daily living (ADLs)\
Patients with peripheral neuropathy > Common Terminology Criteria for Adverse Events (CTCAE) grade 
Patients must have < grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE])
Patients with =< grade  peripheral neuropathy are eligible for this trial using the Common Terminology Criteria for Adverse Events (CTCAE) v., regardless of use of therapy for neuropathy including gabapentin
Clinically significant peripheral neuropathy (defined as >= Common Terminology Criteria for Adverse Events [CTCAE] grade  [version .]), neurosensory or neuromotor toxicity, regardless of causality
Patients must not have >= grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE])
< grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE])
Presence of peripheral neuropathy ? Common Terminology Criteria for Adverse Events (CTCAE) Grade 
Patients must have < grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE])
Preexisting peripheral neuropathy of grade , , or  (per Common Terminology Criteria for Adverse Events v .)
Patients must not have grade  or greater pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE] .)
Pre-existing peripheral neuropathy of Grade , , or  (per Criteria for Adverse Events (CTCAE) v.).
Patients must have < grade  pre-existing peripheral neuropathy per Common Terminology Criteria for Adverse Events (CTCAE)
Peripheral neuropathy of grade  or greater by Common Terminology Criteria for Adverse Events (CTCAE) .; in CTCAE version . grade  sensory neuropathy is defined as \moderate symptoms; limiting instrumental activities of daily living (ADLs)\
Current peripheral neuropathy greater than or equal to Common Terminology Criteria for Adverse Events (CTCAE) Grade  except due to trauma
Patients must have =< grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events [CTCAE] v.)
Patients with pre-existing peripheral neuropathy must have < grade  (per Common Terminology Criteria for Adverse Events [CTCAE] .) at the time of registration
Patients must have < grade  pre-existing peripheral neuropathy (per Common Terminology Criteria for Adverse Events . [CTCAE .])
